[ad_1]
DUBLIN, January 31, 2019 / PRNewswire / –
The bad imaging market by technology (ionization (mammography (digital mammography, 3D mammography, badog), MBI, PET-CT, PEM)), non-ionizing (bad ultrasound, bad MRI, automated ultrasound Breast Thermography) – Global Forecasts to 2023 "has been added to ResearchAndMarkets.com & # 39; s offer
The global bad imaging market is expected to reach $ 4.6 billion from here 2023 from USD 3.1 billion in 2018 at a CAGR of 8.0%.
The growth of this market is largely motivated by factors such as the increasing prevalence of bad cancer, the growth of the geriatric population (age contributing to bad cancer risk) and changing lifestyles, which have increased the general possibility of cancer onset.
However, errors in screening and misdiagnosis, the side effects of radiation exposure and the increasing adoption of refurbished imaging systems are the main factors that should curb the growth of this market. during the forecast period.
The ionizing bad imaging segment is expected to represent the largest market share during the forecast period
Based on technology, the bad imaging market is divided into two categories: ionizing technology (mammography, PET-CT, MBI and PEM), non-ionizing (bad ultrasound, bad MRI, AWBU and bad thermography). and electrical impedance tomography and optical imaging). The ionizing bad imaging sector accounted for the largest portion of this market in 2018, driven by technological advances in ionizing bad imaging technologies and the growing awareness of early detection and diagnosis. bad cancer.
Breast Molecular Imaging (MBI) Segment to Be the Second Largest Growth in the Breast Ion Imaging Market During the Forecast Period
Based on the type, the market for ionizing bad imaging technology is segmented into mammography, PET-CT, MBI and PEM. The MBI segment is expected to experience the second highest growth rate in the market during the forecast period. The MBI technique is simple, fast and extremely sensitive. It can be used in claustrophobic or gadolinium allergic patients, who are the main factors that have motivated its adoption in the bad imaging market.
Europe represents the second largest share of the global market in 2018
The bad imaging market is segmented into four major regions, namely: North America, Europe , the Asia Pacificand the rest of the world. Europe accounted for the second largest share of the global bad imaging market in 2018. Increased number of regulatory approvals for advanced bad imaging modalities, increasing number of collaborations and partnerships distribution between market players and the implementation of various awareness programs by several European organizations. are the main factors in the demand for bad imaging at Europe .
As of 2017, Hologic, Inc. (United States), GE Healthcare (United States), Siemens Healthineers (Germany) and Philips Healthcare (Netherlands) were the main companies in the market.
Key topics covered:
1. Introduction
2 Research Methodology
3 Summary
4 Premium Insights
4.1 Breast Imaging: Market Overview
4.2 Technology Analysis – Breast Imaging Market, by Region
4.3 Mammography Market in Asia-Pacific by Type and Country
4.4 European ionizing bad imaging market, by type and country
4.5 Non-ionizing bad imaging market, by type
4.6 Geographic Overview of the Breast Imaging Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing incidence of bad cancer
5.2.1.2 Increase in investments, funds and public-private subsidies
5.2.1.3 Increased awareness of early detection of bad cancer
5.2.1.4 Growth of the aging population
5.2.2 Restraint
5.2.2.1 High cost of bad imaging systems
5.2.2.2 Unfavorable repayment scenario
5.2.3 Opportunities
5.2.3.1 Emerging economies offer strong growth potential
5.2.3.2 Miniaturization and technological progress
5.2.4 Challenges
5.2.4.1 Side Effects of Radiation Exposure
5.2.4.2 Errors in Breast Cancer Screening and Diagnosis
5.2.4.3 Risk of overdiagnosis and anxiety of the patient
5.2.4.4 Increasing Adoption of Refurbished Imaging Systems
5.3 Market Trends
5.3.1 Artificial intelligence
5.3.2 Personalized approach to bad cancer screening
5.4 Guidelines for Breast Cancer Screening
5.5 Price Analysis
6 Breast imaging market, by technology
6.1 Introduction
6.2 Ionizing Breast Imaging Technologies
6.2.1 Mammography
6.2.1.1 Full Field Digital Mammography
6.2.1.1.1 Ffdm offers significant advantages over conventional badogue mammography, such as the use of lower radiation doses and reduced bad compression pressure
6.2.1.2 Analog Mammography
6.2.1.2.1 Superior accuracy and efficiency offered by digital mammography systems limit the adoption of the badog mammography system
6.2.1.3 Breast tomosynthesis in 3D
6.2.1.3.1 The 3D bad tomosynthesis segment will demonstrate the highest growth rate in the mammography market over the forecast period
6.2.2 Positron Emission Tomography – Computerized Tomography (Pet-Ct)
6.2.2.1 The combined badyzes of the animal and the patient provide a more accurate diagnosis than the individual badyzes carried out.
6.2.3 Molecular imaging of the bad
6.2.3.1 The Mbi technique is simple, fast and extremely sensitive. It can be used for patients who are claustrophobic or allergic to gadolinium.
6.2.4 Positron emission mammography
6.2.4.1 MEP involves exposure to radiation throughout the body, which increases the risk of cancer. A major disadvantage badociated with this technique
6.3 Non-ionizing mammary imaging technologies
6.3.1 Breast ultrasound
6.3.1.1 Cost reduction, increasing awareness and easy availability of ultrasound devices for bad imaging are driving growth in this market
6.3.2 MRI of the bad
6.3.2.1 Technological advances in bad MRI and the increasing demand for technologies that use minimal radiation use are key factors in the growth of this market
6.3.3 Automated whole-bad ultrasonography
6.3.3.1 Awbu helps detect tiny cancers in bad mammograms
6.3.4 Breast thermography
6.3.4.1 This technique is not effective when used as a stand-alone test for bad cancer screening
6.4 Other bad imaging technologies
6.4.1 Optical imaging
6.4.2 Cone beam computer tomography
6.4.3 Electrical impedance tomography
6.5 Cad Software
7 bad imaging market, by region
7.1 Introduction
7.2 North America
7.2.1 US
7.2.1.1 The United States will dominate the North American bad imaging market
7.2.2 Canada
7.2.2.1 Increasing incidence of bad cancer and government initiatives to promote bad cancer awareness to stimulate market growth Canada
7.3 Europe
7.3.1 Germany
7.3.1.1 The wider acceptance of ionizing and non-ionizing bad imaging technologies and the increasing demand for improved diagnostics are the main drivers of market growth in Europe. Germany
7.3.2 la France
7.3.2.1 The rapid population increase and the high number of bad cancers stimulate the adoption of bad imaging technologies la France
7.3.3 UK
7.3.3.1 High rate of bad cancer incidence and public and private initiatives to raise awareness of early detection and detection of bad cancer to stimulate market growth
7.3.4 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.1.1 Growing Geriatric Population and Presence of a Universal Health Care Reimbursement Scenario to Stimulate the Adoption of Breast Imaging Procedures Japan
7.4.2 China
7.4.2.1 Increasing incidence of bad cancer and increase in the number of patients China stimulate the demand for bad imaging in the country
7.4.3 India
7.4.3.1 Government Initiatives to Improve Women's Health to Boost Market Growth India
7.4.4 Rest of the ICCA
7.5 Rest of the world
7.5.1 Latin America
7.5.1.1 Latin America will represent the largest share of the RoW bad imaging market in 2018
7.5.2 Middle East And Africa
7.5.2.1 Improving health care infrastructure and increasing public-private investment to stimulate market growth in the Me & A region
8 competitive landscape
8.1 Introduction
8.2 Competitive Leadership Mapping (Global Market)
8.3 Criteria for inclusion of suppliers
8.4 Diving the seller
8.5 Competitive Leadership Mapping (Smse / Start-Up)
8.6 Analysis of market shares, by category
8.7 Competitive Scenario
9 company profiles
- Aurora, Inc. Imaging Technology
- Canon Inc.
- Cmr Naviscan
- Delphinus Medical Technologies, Inc.
- Dilon Technologies, Inc.
- Fujifilm Holdings Corporation
- GE Healthcare (part of General Electric Company)
- Hologic, Inc.
- Kub Technologies
- Micrima Limited
- Philips Healthcare (part of Koninklijke Philips N.V.)
- Planmed Oy
- Siemens Healthineers (part of Siemens AG)
- Sonocin, Inc.
- Supersonic Imagine
For more information on this report, visit https://www.researchandmarkets.com/research/4cfnwl/global_bad?w=5.
Research and Markets also offers customized research services that provide targeted, comprehensive and personalized research.
Media contact:
Research and markets
Laura Wood, Main director
[email protected]
For E.S.T office hours, call + 1-917-300-0470
For toll-free calls to the United States and Canada + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
American fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com
Source link
